HRMY Harmony Biosciences Holdings Earnings and EPS analysis

Relative Growth: Rel. Growth: 85

Relative Strength: Rel. Strength: 79

Relative Valuation: Rel. Valuation: 73

Relative Profitability: Rel. Profitability: 90

EPS in 2026 (TTM): $3.14

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the current EPS (TTM) is $3.14. Harmony Biosciences Holdings's EPS for 2025 came in at $2.76, marking an increase from $2.56 in 2024. For the quarterly period ending on Jun 30, 2026, HRMY's EPS was $1.3.

HRMY earnings history

Historical annual and quarterly earnings per share (EPS) data for Harmony Biosciences Holdings

EPS (TTM)

$3.14

EPS Growth YoY (Quarterly)

88.4%

EPS (Quarterly)

$1.3

EPS Growth (Quarterly)

132.1%

Harmony Biosciences Holdings had an annual EPS of $2.76, marking an increase of 7.8% from $2.56 in 2024. The quarterly EPS for the period ending Jun 30, 2026, was $1.3, marking a 88.4% increase from the same quarter last year. HRMY's TTM EPS stands at $3.14 as of June 2026. Harmony Biosciences Holdings's EPS for 2024 stood at $2.56, a 18% increase from 2023.

HRMY EPS vs price chart

HRMY EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

88.4%

EPS growth YoY

7.8%

EPS growth 3Y avg

-3.5%

EPS growth 5Y avg

N/A

Harmony Biosciences Holdings has recorded an increase in EPS of 88.4% over the last 12 months (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of -3.5% per year over the past 3 years.

HRMY Earnings Waterfall

Breakdown of revenue, profit and net income for Harmony Biosciences Holdings

HRMY Earnings vs Peers

What are the earnings of HRMY compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
HRMY Harmony Biosciences Holdings Inc	12.89	7.8%	-3.5%	N/A
OPK Opko Health Inc	N/A	-275%	N/A	N/A
ORGO Organogenesis Holdings Inc	N/A	1,700%	10.1%	0%

All data is based on quarterly TTM periods, unless otherwise specified.